POM121L7P

Across TCGA pan-cancer cohorts, POM121L7P RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated POM121L7P data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher POM121L7P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated POM121L7P expression acts as an unfavorable survival marker, although some lineages such as CESC and BLCA show a favorable association.

KICH, UCS, and ACC are the cancer types where POM121L7P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	OS	Tertile	All	0.154	0.894	<.001	135	view →
UCS	OS	Tertile	III,IV	0.144	0.605	.002	90	view →
ACC	OS	Tertile	All	0.114	0.892	<.001	84	view →
CHOL	DFS	Tertile	All	0.045	0.497	.029	36	view →
COAD	DFS	Tertile	II,III,IV	0.631	0.774	.003	33	view →
DLBC	OS	Tertile	All	0.526	0.936	.002	27	view →
MESO	OS	Tertile	III,IV	0.153	0.590	.010	18	view →
CESC	OS	Tertile	IV	1.000	0.240	.040	18	view →
LGG	OS	Tertile	All	0.309	0.469	.006	15	view →
SKCM	OS	Tertile	IV	0.415	0.861	.014	9	view →
STAD	DFS	Tertile	II,III,IV	0.226	0.453	.022	9	view →
READ	DFS	Tertile	III,IV	0.354	0.577	.038	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

POM121L7P–KICH (OS)

Open the KICH breakdown →